Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-04

Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of fluticasone furoate nasal spray for two weeks in Chinese adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone furoate nasal spray (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial, Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2011-02-04